Study of Reslizumab in Participants With Uncontrolled Asthma and Elevated Blood Eosinophils
Clinical trial NCT02452190 · COMPLETED
Trial details
- NCT number
- NCT02452190
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-28
- Primary completion
- 2017-12-04
- Enrollment
- 468
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.